<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Open Congress : News Articles for S.623 Access to Life-Saving Medicine Act</title>
  <link href="http://www.opencongress.org/bill/110-s623/atom_news" rel="self"/>
  <link href="http://www.opencongress.org/bill/110-s623/news" rel="alternate"/>
  <updated>2007-07-02T20:00:00Z</updated>
  <author>
    <name>opencongress.org</name>
  </author>
  <id>tag:opencongress.org,2007:/bill/news/41211</id>
  <entry>
    <title>Support bill to help lower drug prices</title>
    <link href="http://toledoblade.com/apps/pbcs.dll/article?AID=/20070703/OPINION03/707030319" rel="alternate"/>
    <id>tag:opencongress.org,2007-07-02:/commentary/819753</id>
    <updated>2007-07-02T20:00:00Z</updated>
    <author>
      <name>Toledo Blade,&amp;nbsp;OH</name>
    </author>
    <content type="html">
I support the Access to Life-Saving Medicine Act (S. 623, HR 1038) that would provide this statutory pathway and help make critical medicines more available ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://toledoblade.com/apps/pbcs.dll/article?AID=/20070703/OPINION03/707030319&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Medco CEO Lays Out Generic Industry Action Plan</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10351&amp;amp;amp;articleId=94975" rel="alternate"/>
    <id>tag:opencongress.org,2007-06-20:/commentary/819752</id>
    <updated>2007-06-20T20:00:00Z</updated>
    <author>
      <name>FDA news (subscription),&amp;nbsp;VA</name>
    </author>
    <content type="html">
It is &amp;#8220;mandatory&amp;#8221; that Congress pass legislation to create a pathway for follow-on biologics, and the Access to Life-Saving Medicine Act, S. 623 and HR 1038 ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10351&amp;amp;amp;articleId=94975&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>AARP Urges Congress to Pave Way for Generic Biologics</title>
    <link href="http://www.medadnews.com/News/index.cfm?articleid=421900" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-07:/commentary/450585</id>
    <updated>2007-03-07T19:00:00Z</updated>
    <author>
      <name>PharmaLive.com (press release),&amp;nbsp;PA</name>
    </author>
    <content type="html">
S. 623 and HR 1038 would direct the FDA to establish a process for bringing these treatments to market. It would ensure that Americans have improved access ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.medadnews.com/News/index.cfm?articleid=421900&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>FDA to approve safe, cost-effective generic versions of medicines</title>
    <link href="http://www.spiritindia.com/health-care-news-articles-7341.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-07:/commentary/408476</id>
    <updated>2007-03-07T19:00:00Z</updated>
    <author>
      <name>SpiritIndia,&amp;nbsp;India</name>
    </author>
    <content type="html">
S. 623 and HR 1038 would direct the FDA to establish a process for bringing these treatments to market. It would ensure that Americans have improved access ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.spiritindia.com/health-care-news-articles-7341.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>FDA needs authority to approve generic biologics</title>
    <link href="http://www.news-medical.net/?id=22488" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-07:/commentary/408475</id>
    <updated>2007-03-07T19:00:00Z</updated>
    <author>
      <name>News-Medical.net,&amp;nbsp;Australia</name>
    </author>
    <content type="html">
S. 623 and HR 1038 would direct the FDA to establish a process for bringing these treatments to market. It would ensure that Americans have improved access ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.news-medical.net/?id=22488&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>AARP Urges Congress to Pave Way for Generic Biologics</title>
    <link href="http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&amp;amp;amp;STORY=/www/story/03-08-2007/0004542447&amp;amp;amp;EDATE=" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-07:/commentary/407400</id>
    <updated>2007-03-07T19:00:00Z</updated>
    <author>
      <name>PR Newswire (press release),&amp;nbsp;NY</name>
    </author>
    <content type="html">
S. 623 and HR 1038 would direct the FDA to establish a process for bringing these treatments to market. It would ensure that Americans have improved access ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&amp;amp;amp;STORY=/www/story/03-08-2007/0004542447&amp;amp;amp;EDATE=&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
</feed>

